Principal Financial Group
IMNM icon

Principal Financial Group’s Immunome IMNM Stock Holding History

Principal Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.1M Sell
1,376,867
-27,583
-2% -$614K 0.02% 687
2025
Q4 		$30.2M Buy
1,404,450
+299,512
+27% +$5.26M 0.02% 660
2025
Q3 		$12.9M Buy
1,104,938
+762,147
+222% +$7.58M 0.01% 1136
2025
Q2 		$3.19M Buy
+342,791
New +$2.81M ﹤0.01% 1707

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Principal Financial Group's IMNM Position: Q1 2026 in Review

Principal Financial Group reduced its Immunome (IMNM) stake by 2% in Q1 2026, selling an estimated $614K and leaving 1,376,867 shares worth $30.1M. The position accounts for 0.02% of the portfolio, ranked #687.

Principal Financial Group first reported a position in IMNM in Q2 2025 and has held it in 4 quarters since. The position peaked at $30.2M in Q4 2025. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Principal Financial Group held 1,376,867 shares of Immunome worth $30.1M as of Q1 2026.
  • Principal Financial Group sold 27,583 Immunome shares in Q1 2026, an estimated $614K.
  • Immunome made up 0.02% of Principal Financial Group's portfolio in Q1 2026, its #687 holding.
  • Principal Financial Group first reported a position in Immunome in Q2 2025 and has held it in 4 quarters since.
  • Principal Financial Group's Immunome position peaked at $30.2M in Q4 2025.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Principal Financial Group's 13F filing for Q1 2026, filed 4 May 2026.